ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

CNTG Centogene NV

0,399
0,004 (1,01%)
25 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Centogene NV CNTG NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,004 1,01% 0,399 17:25:01
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,4063 0,387 0,4063 0,399 0,395
mais cotações »

Notícias Recentes

Data Hora Fonte Título
20/06/202409:00GLOBEC-Path and CENTOGENE MOU to Enhance Collaboration in..
31/05/202417:30GLOBECENTOGENE Announces Adoption of All Resolutions Tabled at..
15/05/202418:17GLOBECENTOGENE Reports Full Year 2023 Financial Results and..
15/05/202418:10GLOBECENTOGENE Secures Approx. $20 Million to Strengthen Cash..
14/05/202409:30GLOBECENTOGENE and Evotec Discover Promising New Molecule to..
10/05/202407:30GLOBECENTOGENE Biodatabank Grows to Incorporate Disease Insights..
02/04/202417:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notice
19/03/202407:30GLOBECENTOGENE Extends Strategic Partnership With Takeda to..
29/02/202419:00GLOBECENTOGENE Collaborates on Research Published in Science..
28/02/202408:30GLOBECENTOGENE Announces Receipt of Nasdaq Notice of Delisting..
28/02/202408:30GLOBECENTOGENE Explores Strategic Alternatives
25/01/202408:30GLOBECENTOGENE and the Laboratory of Human Genetics of Infectious..
24/01/202408:30GLOBECENTOGENE Receives French Research Tax Credit Accreditation
23/01/202408:30GLOBECENTOGENE and The Michael J. Fox Foundation Announce..
18/01/202408:30GLOBECENTOGENE Announces Preliminary Full Year 2023 Revenue
19/12/202308:30GLOBECENTOGENE Announces Voting Results of Extraordinary General..
13/12/202308:30GLOBECENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study,..
28/11/202308:30GLOBECENTOGENE and Lifera, a Public Investment Fund (PIF)..
14/11/202310:30GLOBECENTOGENE, University College London, and Global Team of..
10/10/202307:30GLOBECENTOGENE Expands Multiomic Diagnostic Portfolio With..
11/09/202309:30GLOBECENTOGENE to Present at H.C. Wainwright 25th Annual Global..
07/09/202318:00GLOBECENTOGENE Reports First Half 2023 Financial Results
01/09/202309:00GLOBECENTOGENE Announces Publication Establishing Lyso-Gb1 as a..
31/08/202317:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notification..
07/08/202307:30GLOBECENTOGENE to Participate in Upcoming Conferences in August
14/07/202307:30GLOBECENTOGENE Regains Compliance With Nasdaq Listing..
12/07/202308:30GLOBECENTOGENE Biodatabank Reveals Unique Genetic Variants in..
02/07/202306:00PRNUSLifera and CENTOGENE, Enter Strategic Collaboration -..
30/06/202317:30GLOBECENTOGENE Announces Approval of All Resolutions Tabled at..
27/06/202308:30GLOBECENTOGENE and Lifera, a Biopharma Company Owned by the PIF,..